Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Queenie Lau"'
Publikováno v:
Int J Surg Case Rep
INTRODUCTION AND IMPORTANCE: Rosette forming Glioneuronal tumours (RGNT) are rare WHO grade I tumours. They have been recognised as a sole entity in the WHO classification since 2007. They are typically described as having a favourable prognosis. Sin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::215407c81a2def1034f804f7014adc1f
https://europepmc.org/articles/PMC10112015/
https://europepmc.org/articles/PMC10112015/
Autor:
Mythily Mariasegaram, Ann-Marie Patch, Conrad Leonard, Admire Matsika, Sean M. Grimmond, Fares Al-Ejeh, Margaret C. Cummings, Rosalind L. Jeffree, Georgia Chenevix-Trench, Oliver Holmes, Leonard Da Silva, Nur Aishah Taib, Adrienne M. Flanagan, Teresa K. Withers, Matthew J. Anderson, Vairavan Narayanan, Ehsan Nourbakhsh, Queenie Lau, Sunil R. Lakhani, J. Lynn Fink, kConFab, Felicity Newell, Katia Nones, Stephen H. Kazakoff, Colleen Niland, Parmjit S. Jat, Ivon Harliwong, Peter T. Simpson, Lynne Reid, Nicola Waddell, Soo Hwang Teo, Karin S. Kassahn, Sebastian Brandner, John V. Pearson, Nick Waddell, Qinying Xu, Scott Wood, Darrin Taylor, Senel Idrisoglu, Peter Wilson, Timothy J. C. Bruxner, Kum Kum Khanna, Craig Nourse, Shivangi Wani, Angelika N. Christ, David Miller, Amy E. McCart Reed, Michael C.J. Quinn, Yock Ping Chow, Jodi M. Saunus, Suzanne Manning, Peter Bailey
Publikováno v:
The Journal of Pathology. 237:363-378
Treatment options for patients with brain metastases (BMs) have limited efficacy and the mortality rate is virtually 100%. Targeted therapy is critically under-utilized, and our understanding of mechanisms underpinning metastatic outgrowth in the bra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8267ec7427eb4bd811359ef5081231a3
https://doi.org/10.1002/path.4583
https://doi.org/10.1002/path.4583
Autor:
Fateme Salehi, Queenie Lau, Kalman Kovacs, Michael E. Fealey, Eva Horvath, Dana Erickson, Ricardo V. Lloyd, Bernd W. Scheithauer, Johann M. Kros
Publikováno v:
Journal of Neuro-Oncology, 104(3), 647-657. Kluwer Academic
MGMT promoter hypermethylation of aggressive pituitary adenomas and pituitary carcinomas and low protein expression are implicated in improved response to treatment with temozolomide (TMZ). The aim of the present study was to investigate MGMT promote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::105f6ec4cc00bd0ba8194913dc823042
https://doi.org/10.1007/s11060-011-0532-6
https://doi.org/10.1007/s11060-011-0532-6
Autor:
Jodi M, Saunus, Michael C J, Quinn, Ann-Marie, Patch, John V, Pearson, Peter J, Bailey, Katia, Nones, Amy E, McCart Reed, David, Miller, Peter J, Wilson, Fares, Al-Ejeh, Mythily, Mariasegaram, Queenie, Lau, Teresa, Withers, Rosalind L, Jeffree, Lynne E, Reid, Leonard, Da Silva, Admire, Matsika, Colleen M, Niland, Margaret C, Cummings, Timothy J C, Bruxner, Angelika N, Christ, Ivon, Harliwong, Senel, Idrisoglu, Suzanne, Manning, Craig, Nourse, Ehsan, Nourbakhsh, Shivangi, Wani, Matthew J, Anderson, J Lynn, Fink, Oliver, Holmes, Stephen, Kazakoff, Conrad, Leonard, Felicity, Newell, Darrin, Taylor, Nick, Waddell, Scott, Wood, Qinying, Xu, Karin S, Kassahn, Vairavan, Narayanan, Nur Aishah, Taib, Soo-Hwang, Teo, Yock Ping, Chow, kConFab, Parmjit S, Jat, Sebastian, Brandner, Adrienne M, Flanagan, Kum Kum, Khanna, Georgia, Chenevix-Trench, Sean M, Grimmond, Peter T, Simpson, Nicola, Waddell, Sunil R, Lakhani
Publikováno v:
The Journal of pathology. 237(3)
Treatment options for patients with brain metastases (BMs) have limited efficacy and the mortality rate is virtually 100%. Targeted therapy is critically under-utilized, and our understanding of mechanisms underpinning metastatic outgrowth in the bra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a3c6b0fb754c0e2ffdf2c8274b669b96
https://pubmed.ncbi.nlm.nih.gov/26172396
https://pubmed.ncbi.nlm.nih.gov/26172396
Publikováno v:
Journal of Integrative Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35ccfc18676b07f93a1915d6513c5c2a
https://doi.org/10.4172/2329-6771.1000112
https://doi.org/10.4172/2329-6771.1000112
Publikováno v:
BMC Anesthesiology
Background Ultrasound gels may contain propylene glycol and glycerol, which are neurotoxic in high concentrations. If the needle passes through gel during regional anesthesia, gel may be injected near the nerve. It is unknown if this practice poses a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c0bc258bd6f72754c856a5b82749737
https://doi.org/10.1186/1471-2253-13-18
https://doi.org/10.1186/1471-2253-13-18
Publikováno v:
World Neurosurgery. 93:484.e5-484.e8
Background Pleomorphic adenoma is a benign neoplastic tumor of the salivary gland. Salivary gland tumors in the intracranial cavity are generally restricted to the pituitary gland and sellar region. To our knowledge, there has been only 1 previous ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e146fa1c91f0e4c7e8c52a8333e1751
https://doi.org/10.1016/j.wneu.2016.07.059
https://doi.org/10.1016/j.wneu.2016.07.059
Publikováno v:
British journal of neurosurgery. 26(5)
Rosette-forming glioneuronal tumour (RGNT) is a rare and novel brain tumour. We present a case of rosette forming glioneuronal tumour of the fourth ventricle and highlight the imaging and histological features of this tumour entity. We also performed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00ca35c53035261f840e6859ecae2501
https://pubmed.ncbi.nlm.nih.gov/22512825
https://pubmed.ncbi.nlm.nih.gov/22512825
Publikováno v:
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 18(8)
Papillary tumour of the pineal region (PTRR) is one of the new tumour entities to be included in the latest World Health Organization classification of central nervous system tumours. We report two illustrative patients, a 25-year-old female who pres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4800443a81b5b7a3fbb9ad3004c13667
https://pubmed.ncbi.nlm.nih.gov/21658955
https://pubmed.ncbi.nlm.nih.gov/21658955
Autor:
Kalman Kovacs, Luis V. Syro, Leon D. Ortiz, Michael D. Cusimano, Ricardo V. Lloyd, Ricardo Gonzalez, Eva Horvath, Humberto Uribe, Queenie Lau, Bernd W. Scheithauer
Publikováno v:
Cancer. 117(3)
Temozolomide, an orally administered alkylating agent, is used to treat malignant gliomas. Recent reports also have documented its efficacy in the treatment of pituitary adenomas and carcinomas. Temozolomide methylates DNA and thereby exhibits an ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5df360f46fa3cf252aeec1d2429e11b
https://pubmed.ncbi.nlm.nih.gov/21387270
https://pubmed.ncbi.nlm.nih.gov/21387270